UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies

Aging (Albany, NY.), 2016-04, Vol.8 (4), p.603-619

2016

Volltextzugriff (PDF)

NRF2 in Cancer: Cross-Talk with Oncogenic Pathways and Involvement in Gammaherpesvirus-Driven Carcinogenesis

International journal of molecular sciences, 2022-12, Vol.24 (1), p.595

2022

Volltextzugriff (PDF)

Oncogenic pathways activated by pro-inflammatory cytokines promote mutant p53 stability: clue for novel anticancer therapies

Cellular and molecular life sciences : CMLS, 2021-03, Vol.78 (5), p.1853-1860

2021

Volltextzugriff (PDF)

The Role of Autophagy in Brain Tumors

Cancers, 2023-09, Vol.15 (19), p.4802

D’Orazi, Gabriella

2023

Volltextzugriff (PDF)

Mutant p53 and Cellular Stress Pathways: A Criminal Alliance That Promotes Cancer Progression

Cancers, 2019-05, Vol.11 (5), p.614

2019

Volltextzugriff (PDF)

p53 Function and Dysfunction in Human Health and Diseases

Biomolecules (Basel, Switzerland), 2023-03, Vol.13 (3), p.506

D'Orazi, Gabriella

2023

Volltextzugriff (PDF)

Interconnected Adaptive Responses: A Way Out for Cancer Cells to Avoid Cellular Demise

Cancers, 2022-06, Vol.14 (11), p.2780

2022

Volltextzugriff (PDF)

HIPK2 in Colon Cancer: A Potential Biomarker for Tumor Progression and Response to Therapies

International journal of molecular sciences, 2024-07, Vol.25 (14), p.7678

2024

Volltextzugriff (PDF)

Recent Advances in p53

Biomolecules (Basel, Switzerland), 2021-02, Vol.11 (2), p.211

D'Orazi, Gabriella

2021

Volltextzugriff (PDF)

Cancer Chemotherapy: Combination with Inhibitors (Volume I)

Cancers, 2024-01, Vol.16 (3), p.607

2024

Volltextzugriff (PDF)

Targeting hypoxia in tumor: a new promising therapeutic strategy

Journal of experimental & clinical cancer research, 2020-01, Vol.39 (1), p.8-8, Article 8

2020

Volltextzugriff (PDF)

Nobel committee honors tumor immunologists

Journal of experimental & clinical cancer research, 2018-10, Vol.37 (1), p.262-262, Article 262

2018

Volltextzugriff (PDF)

The Impact of COVID-19 Infection in Cancer 2020-2021

Cancers, 2022-11, Vol.14 (23), p.5895

2022

Volltextzugriff (PDF)

HIPK2 as a Novel Regulator of Fibrosis

Cancers, 2023-02, Vol.15 (4), p.1059

2023

Volltextzugriff (PDF)

Reactivation of mutant p53 by capsaicin, the major constituent of peppers

Journal of experimental & clinical cancer research, 2016-09, Vol.35 (1), p.136-136, Article 136

2016

Volltextzugriff (PDF)

Carvacrol reduces adipogenic differentiation by modulating autophagy and ChREBP expression

PloS one, 2018-11, Vol.13 (11), p.e0206894-e0206894

2018

Volltextzugriff (PDF)

Quercetin induces apoptosis and autophagy in primary effusion lymphoma cells by inhibiting PI3K/AKT/mTOR and STAT3 signaling pathways

The Journal of nutritional biochemistry, 2017-03, Vol.41, p.124-136

2017

Volltextzugriff (PDF)

Autophagy manipulation as a strategy for efficient anticancer therapies: possible consequences

Journal of experimental & clinical cancer research, 2019-06, Vol.38 (1), p.262-262, Article 262

2019

Volltextzugriff (PDF)

The Sweet Side of HIPK2

Cancers, 2023-05, Vol.15 (10), p.2678

2023

Volltextzugriff (PDF)

HIPK2 in Angiogenesis: A Promising Biomarker in Cancer Progression and in Angiogenic Diseases

Cancers, 2023-03, Vol.15 (5), p.1566

2023

Volltextzugriff (PDF)

Apigenin, by activating p53 and inhibiting STAT3, modulates the balance between pro-apoptotic and pro-survival pathways to induce PEL cell death

Journal of experimental & clinical cancer research, 2017-11, Vol.36 (1), p.167-167, Article 167

2017

Volltextzugriff (PDF)

ATF6 supports lysosomal function in tumor cells to enable ER stress-activated macroautophagy and CMA: impact on mutant TP53 expression

Autophagy, 2024-08, Vol.20 (8), p.1854-1867

2024

Volltextzugriff (PDF)

High glucose dephosphorylates serine 46 and inhibits p53 apoptotic activity

Journal of experimental & clinical cancer research, 2014-09, Vol.33 (1), p.79-79, Article 79

2014

Volltextzugriff (PDF)

Concomitant reduction of c-Myc expression and PI3K/AKT/mTOR signaling by quercetin induces a strong cytotoxic effect against Burkitt’s lymphoma

The international journal of biochemistry & cell biology, 2016-10, Vol.79, p.393-400

2016

Volltextzugriff (PDF)

Updates on HIPK2: a resourceful oncosuppressor for clearing cancer

Journal of experimental & clinical cancer research, 2012-08, Vol.31 (1), p.63-63, Article 63

2012

Volltextzugriff (PDF)

1 – 25 von 138

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(126)
Mit Volltextzugriff
(131)

Publikationsform

Artikel
(136)
Buchkapitel
(2)

Sprache

Englisch
(138)

Erscheinungsjahr

n.n

Thema

Science & Technology
(109)
Life Sciences & Biomedicine
(102)
Humans
(80)
Apoptosis
(56)
Oncology
(53)
Cancer
(50)
Proteins
(47)
Tumor Suppressor Protein P53 - Metabolism
(42)
Cell Line, Tumor
(41)
Biochemistry & Molecular Biology
(37)
P53
(34)
Tumor Suppressor Protein P53 - Genetics
(33)
Kinases
(32)
Cancer Therapies
(31)
Cell Biology
(31)
Mutation
(28)
Tumors
(28)
Animals
(25)
Phosphorylation
(25)
Autophagy
(24)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Experimental & Clinical Cancer Research
(16)
Plos One
(12)
Cancers
(11)
Biomolecules
(10)
International Journal Of Molecular Sciences
(5)
Oncotarget
(4)
Aging
(3)
Biochemical And Biophysical Research Communications
(3)
Biomedicines
(3)
Cancer Letters
(3)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies

NRF2 in Cancer: Cross-Talk with Oncogenic Pathways and Involvement in Gammaherpesvirus-Driven Carcinogenesis

Oncogenic pathways activated by pro-inflammatory cytokines promote mutant p53 stability: clue for novel anticancer therapies

The Role of Autophagy in Brain Tumors

Mutant p53 and Cellular Stress Pathways: A Criminal Alliance That Promotes Cancer Progression

p53 Function and Dysfunction in Human Health and Diseases

Interconnected Adaptive Responses: A Way Out for Cancer Cells to Avoid Cellular Demise

HIPK2 in Colon Cancer: A Potential Biomarker for Tumor Progression and Response to Therapies

Recent Advances in p53

Cancer Chemotherapy: Combination with Inhibitors (Volume I)

Targeting hypoxia in tumor: a new promising therapeutic strategy

Nobel committee honors tumor immunologists

The Impact of COVID-19 Infection in Cancer 2020-2021

HIPK2 as a Novel Regulator of Fibrosis

Reactivation of mutant p53 by capsaicin, the major constituent of peppers

Carvacrol reduces adipogenic differentiation by modulating autophagy and ChREBP expression

Quercetin induces apoptosis and autophagy in primary effusion lymphoma cells by inhibiting PI3K/AKT/mTOR and STAT3 signaling pathways

Autophagy manipulation as a strategy for efficient anticancer therapies: possible consequences

The Sweet Side of HIPK2

HIPK2 in Angiogenesis: A Promising Biomarker in Cancer Progression and in Angiogenic Diseases

Apigenin, by activating p53 and inhibiting STAT3, modulates the balance between pro-apoptotic and pro-survival pathways to induce PEL cell death

ATF6 supports lysosomal function in tumor cells to enable ER stress-activated macroautophagy and CMA: impact on mutant TP53 expression

High glucose dephosphorylates serine 46 and inhibits p53 apoptotic activity

Concomitant reduction of c-Myc expression and PI3K/AKT/mTOR signaling by quercetin induces a strong cytotoxic effect against Burkitt’s lymphoma

Updates on HIPK2: a resourceful oncosuppressor for clearing cancer

Suchergebnisse filtern